Prime Medicine to Present at Jefferies Global Healthcare Conference

Prime Medicine announced that its CEO, Allan Reine, will participate in a fireside chat at the Jefferies Global Healthcare Conference in London. The company focuses on developing curative genetic therapies using its proprietary Prime Editing platform.
Why it matters
This event provides insight into the progress and strategic direction of a biotechnology firm working on advanced gene-editing technologies.
CAMBRIDGE, Mass., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that Allan Reine, M.D., Chief Executive Officer of Prime Medicine, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Monday, November 16, 2026, at 4:00 p.m. GMT (11:00 a.m. ET) in London, United Kingdom.
A live audio webcast of the presentation will be available under "Events & Presentations” in the News & Events section of the Company’s website at www.primemedicine.com. A replay of the webcast will be available on the Prime Medicine website for 90 days following the event.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in